Cart
sales@molnova.com
WEB-1868
CAS No. 96449-69-3
WEB-1868( WEB 1868 | WEB1868 )
Catalog No. M27215 CAS No. 96449-69-3
WEB-1868 is an agent of biochemical.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 51 | In Stock |
|
| 50MG | 75 | In Stock |
|
| 100MG | 112 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 276 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWEB-1868
-
NoteResearch use only, not for human use.
-
Brief DescriptionWEB-1868 is an agent of biochemical.
-
DescriptionWEB-1868 is an agent of biochemical.
-
In Vitro——
-
In Vivo——
-
SynonymsWEB 1868 | WEB1868
-
PathwayOthers
-
TargetOther Targets
-
RecptorM1 muscarininc
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number96449-69-3
-
Formula Weight205.257
-
Molecular FormulaC12H15NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCC1CN(Cc2ccccc2)C(=O)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sheffler DJ, et al. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning. Mol Pharmacol. 2009 Aug;76(2):356-68.
molnova catalog
related products
-
Icosabutate
Icosabutate (NST-4016) is an orally active derivative of eicosapentaenoic acid that inhibits hepatic inflammation and fibrosis in NASH, improves cardiovascular risk profiles in statin-treated patients with residual hypertriglyceridemia, lowers triglycerides, and may be useful in studies of liver fibrosis and atherosclerosis.
-
Transdermal Peptide ...
Transdermal Peptide TFA (TD 1 Peptide TFA) is an 11-amino acid polypeptide that binds to Na+/K+ -atpase beta-subunit (ATP1B1) and interacts with the C terminal of ATP1B1.Transdermal Peptide TFA can enhance the transmission of some large molecules in the skin.
-
2-Furoyl-LIGRLO-amid...
2-Furoyl-LIGRLO-amide is a potent and selective protease-activated receptor 2 (PAR2) agonist.
